Home › NDC Lookup › RxCUI directory › RxCUI 860103

Ketorolac tromethamine 4 MG/ML Ophthalmic Solution — RxCUI 860103

RxNorm drug concept · Semantic clinical drug
RxCUI 860103 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI860103
Official nameKetorolac tromethamine 4 MG/ML Ophthalmic Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asketorolac tromethamine 0.4 % Ophthalmic Solution
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)11,828 prescriptions · 39 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ketorolac Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ketorolac eye drops are used for two things: relieving itchy eyes from seasonal allergies, and reducing inflammation in the eye after cataract surgery. They belong to a class of dr...
  • Yes, stinging and burning right after putting in the drops is the most commonly reported side effect — up to 40% of people in clinical studies noticed it. The good news is it's usu...
  • Will these drops sting when I put them in?
  • No — you should not put the drops in while you're wearing contact lenses. Remove your contacts before applying the drops, and wait before putting them back in. Your prescriber or t...
📖 Read our full Ketorolac Ophthalmic guide →

🕸️ Concept Web — How Ketorolac tromethamine 4 MG/ML Ophthalmic Soluti... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ketorolac tromethamine 4 MG/ML Ophthalmic Solution RxCUI 860103

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Ketorolac 35827
    • Ketorolac tromethamine 28200
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Acular 152819
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ketorolac Ophthalmic Solution 377446
    • Ketorolac tromethamine Ophthalmic Solution 2647303
    • Ketorolac Ophthalmic Product 1160968
    • Ketorolac tromethamine Ophthalmic Product 2661885
    • Ketorolac Ophthalmic Solution [Acular] 363846
    • Ketorolac tromethamine Ophthalmic Solution [Acular] 2655382
    • Acular Ophthalmic Product 1169934
    • Ophthalmic Solution 7670
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ketorolac tromethamine 4 MG/ML SCDC · 860102
  • Ketorolac Ophthalmic Solution SCDF · 377446
  • Ketorolac tromethamine Ophthalmic Solution SCDFP · 2647303
  • Ketorolac Ophthalmic Product SCDG · 1160968
  • Ketorolac tromethamine Ophthalmic Product SCDGP · 2661885

Brand-Name Concepts

  • Ketorolac tromethamine 4 MG/ML Ophthalmic Solution [Acular] SBD · 860105
  • Ketorolac tromethamine 4 MG/ML [Acular] SBDC · 860104
  • Ketorolac Ophthalmic Solution [Acular] SBDF · 363846
  • Ketorolac tromethamine Ophthalmic Solution [Acular] SBDFP · 2655382
  • Acular Ophthalmic Product SBDG · 1169934
  • Acular BN · 152819

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 860103 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00023-9277-05 1 BOTTLE, DROPPER in 1 CARTON (0023-9277-05) / 5 mL in 1 BO... ACULAR LS Allergan, Inc. 2003-08-19
50090-3550-00 1 BOTTLE, DROPPER in 1 CARTON (50090-3550-0) / 5 mL in 1 BO... KETOROLAC TROMETHAMINE A-S Medication Solutions 2018-08-23
60758-0773-05 1 BOTTLE, DROPPER in 1 CARTON (60758-773-05) / 5 mL in 1 BO... KETOROLAC TROMETHAMINE Pacific Pharma, Inc. 2013-11-21
65862-0775-05 1 BOTTLE in 1 CARTON (65862-775-05) / 5 mL in 1 BOTTLE Ketorolac Tromethamine Aurobindo Pharma Limited 2018-11-15
Observed labelers: A-S Medication Solutions (1) · Allergan, Inc. (1) · Aurobindo Pharma Limited (1) · Pacific Pharma, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$33.6793
Range $12.8084–$54.5502 · middle 50% $23.2439–$44.1148 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.